2023 was a troublesome calendar year with the biopharma field, with many providers downsizing and restructuring their workforces to stay afloat. You will discover signs of recovery, as mergers and acquisitions picked up throughout the pharmaceutical and existence sciences field while in the latter Portion of 2023 and also have https://sites.google.com/view/bio-sites/blog